Related Experiment Video
Updated: May 2, 2026
02:08
Surgical Bone Implantation Technique for Rat Tibia Models of Diabetes and Osteoporosis
Published on: July 5, 2024
1.7K
Unveiling GDF-15: a new frontier in combating diabetic osteoporosis
Nan Wang1, Yingyi Gao1, Ning Bai2
1Department of Medicine, Wuxi Medicine College, Jiangnan University, Wuxi, Jiangsu, China.
Frontiers in Medicine
|May 1, 2026
Summary
Diabetic osteoporosis (DOP), a diabetes mellitus complication, involves bone density loss. Growth differentiation factor-15 (GDF-15) shows abnormal expression in DOP and may offer therapeutic targets.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Bone Biology
Background:
- Diabetic osteoporosis (DOP) is a significant complication of diabetes mellitus (DM), characterized by reduced bone density and increased fracture risk.
- Disordered bone metabolism in DM contributes to DOP, highlighting the need for understanding underlying mechanisms.
- Growth differentiation factor-15 (GDF-15), a TGF-β superfamily member, is implicated in metabolic diseases and bone cell regulation.
Purpose of the Study:
- To review current research on the role of GDF-15 in diabetic osteoporosis.
- To elucidate the pathophysiological mechanisms linking GDF-15 to DOP.
- To explore the potential of GDF-15 as a therapeutic target for DOP.
Main Methods:
- Literature review of basic and clinical research on GDF-15 and DOP.
- Analysis of GDF-15 expression patterns in DOP patients.
- Investigation of potential mediating factors such as insulin resistance, hyperglycemia, ferroptosis, and inflammation.
Main Results:
- GDF-15 is abnormally expressed in patients with diabetic osteoporosis.
- GDF-15's role in regulating osteoblasts and osteoclasts suggests involvement in DOP pathogenesis.
- Potential mechanisms include insulin resistance, hyperglycemic toxicity, ferroptosis, and inflammatory responses.
Conclusions:
- GDF-15 is a key factor in the development and progression of diabetic osteoporosis.
- Further research is needed to fully understand GDF-15's specific pathways in DOP.
- GDF-15 presents a promising target for novel therapeutic strategies against diabetic osteoporosis.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
1.2K
07:45Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
809
Related Concept Videos
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
01:31Diabetic Foot Ulcer
33
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory...
33
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:26Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K